[HTML][HTML] N6-methyladenosine modification in ischemic stroke: Functions, regulation, and therapeutic potential

F Han - Heliyon, 2024 - cell.com
Abstract N 6-methyladenosine (m 6 A) modification is the most frequently occurring internal
modification in eukaryotic RNAs. By modulating various aspects of the RNA life cycle, it has …

[HTML][HTML] miR-let-7a inhibits sympathetic nerve remodeling after myocardial infarction by downregulating the expression of nerve growth factor

Y Jing, L Qi, X Zhang, L Zheng, P Yang, J Yin, Y Shi… - Open …, 2024 - degruyter.com
Objective Sympathetic hyperinnervation following myocardial infarction (MI) is one of the
primary causes of ventricular arrhythmias (VAs) after MI. Nerve growth factor (NGF) is a key …

Epitranscriptome Changes in Neurodegenerative Diseases and the Potential Strategy for the Therapeutics

N Suga, Y Ikeda, S Yoshikawa, K Taniguchi… - 2023 - preprints.org
Abstract Changes in epitranscriptome with N6‐methyladenine (m6A) modification could be
involved in the development of multiple diseases, which might be a prevalent modification of …

miR-let-7a inhibits sympathetic nerve remodelling after myocardial infarction by downregulating the expression of nerve growth factor

P Yang - 2023 - researchsquare.com
Objective Sympathetic hyperinnervation following myocardial infarction (MI) is a one of the
primary causes of ventricular arrhythmias (VAs) after MI. Nerve growth factor (NGF) is a key …

N6-Methyladenosine Modification in Stroke: Functions, Regulation and Therapeutic Potential

H Wu, F Han - Regulation and Therapeutic Potential - papers.ssrn.com
Abstract N6-methyladenosine (m6A) modification is the most abundant internal
modifications of eukaryotic RNAs, which is involved in various pathological and …